Amman, Jordan: Hikma Pharmaceuticals PLC (Hikma, Group), the multinational pharmaceutical group, today provides an update on ...

Tirzepatide (Mounjaro) launched in India in March 2025, promising new hope for diabetes and obesity treatment. An expert ...

The market for anti-obesity drugs has been growing for a while, but is finally about to take off with the entry of two global ...

This is the molecule behind Novo Nordisk's white-hot ... It's also gearing up to sell biosimilars of Novo Nordisk diabetes treatment liraglutide. Investors plowed into Hims & Hers stock that ...

The Global Generic Drugs Market achieved a valuation of $487.21 Billion in 2024 and is anticipated to exceed $898 Billion by ...

A study published earlier this January, for instance, found some evidence that liraglutide (an older GLP ... naturally occurring molecule that could help people lose weight—without the ...

Undaunted, on Tuesday, Hims & Hers announced it is to offer branded versions of tirzepatide-- the molecule in the other FDA-approved obesity jab, Eli Lilly's Zepbound. It's also gearing up to sell ...

The reason Lilly is worth so much in the market's eyes is down to one drug molecule, tirzepatide ... even further by adding access to generic liraglutide and branded tirzepatide through our ...